Efficacy and safety of tozorakimab in moderate-to-severe atopic dermatitis: A Phase 2a randomized controlled trial (FRONTIER-2)
托佐拉单抗治疗中重度特应性皮炎的疗效和安全性:一项 2a 期随机对照试验 (FRONTIER-2)
期刊:Journal of the European Academy of Dermatology and Venereology
影响因子:8
doi:10.1111/jdv.20388
Silverberg, J I; Mustapa, M N; Reid, F; Lei, A; Smith, R; Moate, R; Kelly, A; Chen, R; Gavala, M; Jimenez, E; Belvisi, M G; Sadiq, M W; Kell, C; Pandya, H C